Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Patterns of utilization and effects of hospital-specific factors on physical, occupational, and speech therapy for critically ill patients with acute respiratory failure in the USA: results of a 5-year sample.

Prohaska CC, Sottile PD, Nordon-Craft A, Gallagher MD, Burnham EL, Clark BJ, Ho M, Kiser TH, Vandivier RW, Liu W, Schenkman M, Moss M.

Crit Care. 2019 May 16;23(1):175. doi: 10.1186/s13054-019-2467-9.

2.

Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers.

Logue EC, Neff CP, Mack DG, Martin AK, Fiorillo S, Lavelle J, Vandivier RW, Campbell TB, Palmer BE, Fontenot AP.

J Immunol. 2019 Mar 1;202(5):1363-1372. doi: 10.4049/jimmunol.1801105. Epub 2019 Jan 21.

PMID:
30665939
3.

Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.

Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW; Colorado Pulmonary Outcomes Research Group (CPOR).

Pharmacotherapy. 2019 Mar;39(3):242-252. doi: 10.1002/phar.2221.

PMID:
30663791
4.

Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.

Reynolds PM, Van Matre ET, Wright GC, McQueen RB, Burnham EL, Ho PJM, Moss M, Vandivier RW, Kiser TH; Colorado Pulmonary Outcomes Research Group (CPOR).

Pharmacotherapy. 2019 Mar;39(3):232-241. doi: 10.1002/phar.2212. Epub 2019 Jan 21.

PMID:
30592541
5.

The authors reply.

Kiser TH, Burnham EL, Clark B, Ho PM, Allen RR, Moss M, Vandivier RW.

Crit Care Med. 2018 Dec;46(12):e1224-e1225. doi: 10.1097/CCM.0000000000003453. No abstract available.

PMID:
30444823
6.

Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.

Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH.

J Thromb Haemost. 2018 Dec;16(12):2492-2500. doi: 10.1111/jth.14317. Epub 2018 Nov 15.

PMID:
30347498
7.

Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism.

Kiser TH, Burnham EL, Clark B, Ho PM, Allen RR, Moss M, Vandivier RW.

Crit Care Med. 2018 Oct;46(10):1617-1625. doi: 10.1097/CCM.0000000000003288.

PMID:
29979222
8.

African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure.

Breathett K, Liu WG, Allen LA, Daugherty SL, Blair IV, Jones J, Grunwald GK, Moss M, Kiser TH, Burnham E, Vandivier RW, Clark BJ, Lewis EF, Mazimba S, Battaglia C, Ho PM, Peterson PN.

JACC Heart Fail. 2018 May;6(5):413-420. doi: 10.1016/j.jchf.2018.02.015. Erratum in: JACC Heart Fail. 2018 Jul;6(7):617.

9.

The authors reply.

Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, Ho PM, Kiser TH, Vandivier RW, Moss M.

Crit Care Med. 2018 Apr;46(4):e347-e348. doi: 10.1097/CCM.0000000000002984. No abstract available.

PMID:
29538131
10.

Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease.

Ghosh M, Miller YE, Vandivier RW; all authors.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1645-1646. doi: 10.1164/rccm.201801-0103LE. No abstract available.

PMID:
29385351
11.

An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.

Sottile PD, Kiser TH, Burnham EL, Ho PM, Allen RR, Vandivier RW, Moss M; Colorado Pulmonary Outcomes Research Group (CPOR).

Am J Respir Crit Care Med. 2018 Apr 1;197(7):897-904. doi: 10.1164/rccm.201706-1132OC.

12.

Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.

Ghosh M, Miller YE, Nakachi I, Kwon JB, Barón AE, Brantley AE, Merrick DT, Franklin WA, Keith RL, Vandivier RW.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):885-896. doi: 10.1164/rccm.201704-0667OC.

13.

Outcomes of ICU Patients With a Discharge Diagnosis of Critical Illness Polyneuromyopathy: A Propensity-Matched Analysis.

Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, Ho PM, Kiser TH, Vandivier RW, Moss M.

Crit Care Med. 2017 Dec;45(12):2055-2060. doi: 10.1097/CCM.0000000000002763.

14.

The respiratory tract microbial biogeography in alcohol use disorder.

Samuelson DR, Burnham EL, Maffei VJ, Vandivier RW, Blanchard EE, Shellito JE, Luo M, Taylor CM, Welsh DA.

Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L107-L117. doi: 10.1152/ajplung.00277.2017. Epub 2017 Aug 31.

15.

A Survey of Corticosteroid Dosing for Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Assisted Ventilation.

Kiser TH, Sevransky JE, Krishnan JA, Tonascia J, Wise RA, Checkley W, Walsh J, Sullivan JB, Wilson KC, Barker A, Moss M, Vandivier RW.

Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):186-193. doi: 10.15326/jcopdf.4.3.2016.0168.

16.

Understanding the Relevance of the Mouse Cigarette Smoke Model of COPD: Peering through the Smoke.

Vandivier RW, Ghosh M.

Am J Respir Cell Mol Biol. 2017 Jul;57(1):3-4. doi: 10.1165/rcmb.2017-0110ED. No abstract available.

17.

High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic Review.

Bonilla Arcos D, Krishnan JA, Vandivier RW, Sevransky JE, Checkley W, Kiser TH, Sullivan JL, Walsh JW, Wise RA, Wilson KC.

Chronic Obstr Pulm Dis. 2016 Feb 17;3(2):580-588. doi: 10.15326/jcopdf.3.2.2015.0178.

18.

Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.

Moazed F, Burnham EL, Vandivier RW, O'Kane CM, Shyamsundar M, Hamid U, Abbott J, Thickett DR, Matthay MA, McAuley DF, Calfee CS.

Thorax. 2016 Dec;71(12):1130-1136. doi: 10.1136/thoraxjnl-2015-207886. Epub 2016 Feb 2.

19.

Speckle Tracking Echocardiography to Evaluate for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.

Rice JL, Stream AR, Fox DL, Geraci MW, Vandivier RW, Dorosz JL, Bull TM.

COPD. 2016 Oct;13(5):595-600. doi: 10.3109/15412555.2015.1134468. Epub 2016 Feb 1.

PMID:
26829151
20.

Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells.

Gaydos J, McNally A, Guo R, Vandivier RW, Simonian PL, Burnham EL.

Am J Physiol Lung Cell Mol Physiol. 2016 Mar 15;310(6):L507-18. doi: 10.1152/ajplung.00242.2015. Epub 2016 Jan 8.

21.

Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?

Kiser TH, Vandivier RW.

Curr Opin Pulm Med. 2015 Mar;21(2):142-8. doi: 10.1097/MCP.0000000000000142. Review.

PMID:
25575365
22.

Learning to act on secondhand tobacco smoke exposure to limit risk for coronary heart disease.

Vandivier RW.

JAMA Intern Med. 2015 Jan;175(1):136. doi: 10.1001/jamainternmed.2014.4046. No abstract available.

PMID:
25383686
23.

Early administration of infliximab for severe ipilimumab-related diarrhea in a critically ill patient.

Merrill SP, Reynolds P, Kalra A, Biehl J, Vandivier RW, Mueller SW.

Ann Pharmacother. 2014 Jun;48(6):806-10. doi: 10.1177/1060028014528152. Epub 2014 Mar 20.

PMID:
24651165
24.

Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.

Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW.

Am J Respir Crit Care Med. 2014 May 1;189(9):1052-64. doi: 10.1164/rccm.201401-0058OC.

PMID:
24617842
25.

Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells.

Tanaka T, Doe JM, Horstmann SA, Ahmad S, Ahmad A, Min SJ, Reynolds PR, Suram S, Gaydos J, Burnham EL, Vandivier RW.

J Biol Chem. 2014 Apr 11;289(15):10466-75. doi: 10.1074/jbc.M113.482299. Epub 2014 Feb 25.

26.

Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni.

Graham BB, Chabon J, Gebreab L, Poole J, Debella E, Davis L, Tanaka T, Sanders L, Dropcho N, Bandeira A, Vandivier RW, Champion HC, Butrous G, Wang XJ, Wynn TA, Tuder RM.

Circulation. 2013 Sep 17;128(12):1354-64. doi: 10.1161/CIRCULATIONAHA.113.003072. Epub 2013 Aug 19.

27.

Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice.

Bhargava R, Janssen W, Altmann C, Andrés-Hernando A, Okamura K, Vandivier RW, Ahuja N, Faubel S.

PLoS One. 2013 May 8;8(5):e61405. doi: 10.1371/journal.pone.0061405. Print 2013.

28.

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations.

Vandivier RW, Linderman DJ, Koff PB.

Ann Intern Med. 2012 Oct 2;157(7):530; author reply 530-1. doi: 10.7326/0003-4819-157-7-201210020-00018. No abstract available.

PMID:
23027327
29.

Vascular endothelial growth factor enhances macrophage clearance of apoptotic cells.

Kearns MT, Dalal S, Horstmann SA, Richens TR, Tanaka T, Doe JM, Boe DM, Voelkel NF, Taraseviciene-Stewart L, Janssen WJ, Lee CG, Elias JA, Bratton D, Tuder RM, Henson PM, Vandivier RW.

Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L711-8. doi: 10.1152/ajplung.00116.2011. Epub 2012 Feb 3.

30.

Effect of integrated care on advanced chronic obstructive pulmonary disease in high-mortality rural areas.

Linderman DJ, Koff PB, Freitag TJ, Min SJ, Vandivier RW.

Arch Intern Med. 2011 Dec 12;171(22):2059-61. doi: 10.1001/archinternmed.2011.576. No abstract available.

PMID:
22158579
31.

Alveolar macrophage gene expression is altered in the setting of alcohol use disorders.

Burnham EL, Phang TL, House R, Vandivier RW, Moss M, Gaydos J.

Alcohol Clin Exp Res. 2011 Feb;35(2):284-94. doi: 10.1111/j.1530-0277.2010.01344.x. Epub 2010 Dec 1.

32.

Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages.

Petrusca DN, Gu Y, Adamowicz JJ, Rush NI, Hubbard WC, Smith PA, Berdyshev EV, Birukov KG, Lee CH, Tuder RM, Twigg HL 3rd, Vandivier RW, Petrache I.

J Biol Chem. 2010 Dec 17;285(51):40322-32. doi: 10.1074/jbc.M110.137604. Epub 2010 Oct 18.

33.

PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.

Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL.

Blood. 2010 Nov 25;116(22):4512-22. doi: 10.1182/blood-2010-02-272005. Epub 2010 Aug 6.

34.

Acute and chronic alcohol exposure impair the phagocytosis of apoptotic cells and enhance the pulmonary inflammatory response.

Boé DM, Richens TR, Horstmann SA, Burnham EL, Janssen WJ, Henson PM, Moss M, Vandivier RW.

Alcohol Clin Exp Res. 2010 Oct;34(10):1723-32. doi: 10.1111/j.1530-0277.2010.01259.x. Epub 2010 Jul 1.

35.

TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation.

Borges VM, Vandivier RW, McPhillips KA, Kench JA, Morimoto K, Groshong SD, Richens TR, Graham BB, Muldrow AM, Van Heule L, Henson PM, Janssen WJ.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L586-95. doi: 10.1152/ajplung.90569.2008. Epub 2009 Jul 31.

36.

Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences.

Vandivier RW, Richens TR, Horstmann SA, deCathelineau AM, Ghosh M, Reynolds SD, Xiao YQ, Riches DW, Plumb J, Vachon E, Downey GP, Henson PM.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L677-86. doi: 10.1152/ajplung.00030.2009. Epub 2009 Jul 24.

37.

Alcohol abuse and pulmonary disease.

Boé DM, Vandivier RW, Burnham EL, Moss M.

J Leukoc Biol. 2009 Nov;86(5):1097-104. doi: 10.1189/jlb.0209087. Epub 2009 Jul 14. Review.

38.

Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA.

Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, Boé DM, Morimoto K, Bowler RP, Day BJ, Janssen WJ, Henson PM, Vandivier RW.

Am J Respir Crit Care Med. 2009 Jun 1;179(11):1011-21. doi: 10.1164/rccm.200807-1148OC. Epub 2009 Mar 5.

39.

Proactive integrated care improves quality of life in patients with COPD.

Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW.

Eur Respir J. 2009 May;33(5):1031-8. doi: 10.1183/09031936.00063108. Epub 2009 Jan 7.

40.

Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, Henson PM, Bratton DL.

Blood. 2009 Feb 26;113(9):2047-55. doi: 10.1182/blood-2008-05-160564. Epub 2008 Oct 24.

41.

Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells.

Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM.

J Immunol. 2008 Sep 1;181(5):3575-85.

42.

Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha.

Janssen WJ, McPhillips KA, Dickinson MG, Linderman DJ, Morimoto K, Xiao YQ, Oldham KM, Vandivier RW, Henson PM, Gardai SJ.

Am J Respir Crit Care Med. 2008 Jul 15;178(2):158-67. doi: 10.1164/rccm.200711-1661OC. Epub 2008 Apr 17.

43.

The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective.

Vandivier RW, Voelkel NF.

COPD. 2005 Mar;2(1):177-84. Review.

PMID:
17136979
44.

Cell death, remodeling, and repair in chronic obstructive pulmonary disease?

Henson PM, Vandivier RW, Douglas IS.

Proc Am Thorac Soc. 2006 Nov;3(8):713-7. Review.

45.

Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock.

Kalil AC, Sevransky JE, Myers DE, Esposito C, Vandivier RW, Eichacker P, Susla GM, Solomon SB, Csako G, Costello R, Sittler KJ, Banks S, Natanson C, Danner RL.

Crit Care Med. 2006 Nov;34(11):2719-28.

PMID:
16971848
46.

Statins enhance clearance of apoptotic cells through modulation of Rho-GTPases.

Morimoto K, Janssen WJ, Fessler MB, Xiao YQ, McPhillips KA, Borges VM, Kench JA, Henson PM, Vandivier RW.

Proc Am Thorac Soc. 2006 Aug;3(6):516-7. No abstract available.

PMID:
16921133
47.

State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease.

Henson PM, Cosgrove GP, Vandivier RW.

Proc Am Thorac Soc. 2006 Aug;3(6):512-6. Review. No abstract available.

48.

ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages.

Jehle AW, Gardai SJ, Li S, Linsel-Nitschke P, Morimoto K, Janssen WJ, Vandivier RW, Wang N, Greenberg S, Dale BM, Qin C, Henson PM, Tall AR.

J Cell Biol. 2006 Aug 14;174(4):547-56.

49.

Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.

Vandivier RW, Henson PM, Douglas IS.

Chest. 2006 Jun;129(6):1673-82. Review.

PMID:
16778289
50.

Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.

Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW.

J Immunol. 2006 Jun 15;176(12):7657-65.

Supplemental Content

Loading ...
Support Center